Adapalene gel 0.3% for the treatment of acne vulgaris: A multicenter, randomized, double-blind, controlled, phase III trial

Diane Thiboutot, David M. Pariser, Nancy Egan, Javier Flores, James H. Herndon, Norman B. Kanof, Steven E. Kempers, Stuart Maddin, Yves P. Poulin, David C. Wilson, Joyce Hwa, Yin Liu, Michael Graeber

Research output: Contribution to journalArticle

70 Scopus citations

Abstract

Background: A new 0.3% gel formulation of adapalene has been developed. Objective: We sought to provide evidence of the superiority of adapalene gel 0.3% over adapalene gel 0.1% and gel vehicle in the treatment of acne. Methods: A total of 653 patients were randomized to receive adapalene gel 0.3%, adapalene gel 0.1%, or vehicle once daily for 12 weeks (2:2:1 randomization). Analysis for efficacy was conducted on correlated repeated measurements at weeks 8 and 12 using Generalized Estimating Equation methodology. Results: Adapalene gel 0.3% was significantly superior to adapalene gel 0.1% and vehicle in success rate, total lesion count, and inflammatory lesion count. A consistent, dose-dependent effect was demonstrated for all efficacy measures. Signs and symptoms were mostly mild to moderate and transient in nature. Limitations: Adjunctive topical or oral agents and their impact on acne were not studied in this trial. Conclusions: Adapalene gel 0.3% was effective and well tolerated in the treatment of acne.

Original languageEnglish (US)
Pages (from-to)242-250
Number of pages9
JournalJournal of the American Academy of Dermatology
Volume54
Issue number2
DOIs
StatePublished - Feb 1 2006

All Science Journal Classification (ASJC) codes

  • Dermatology

Fingerprint Dive into the research topics of 'Adapalene gel 0.3% for the treatment of acne vulgaris: A multicenter, randomized, double-blind, controlled, phase III trial'. Together they form a unique fingerprint.

  • Cite this

    Thiboutot, D., Pariser, D. M., Egan, N., Flores, J., Herndon, J. H., Kanof, N. B., Kempers, S. E., Maddin, S., Poulin, Y. P., Wilson, D. C., Hwa, J., Liu, Y., & Graeber, M. (2006). Adapalene gel 0.3% for the treatment of acne vulgaris: A multicenter, randomized, double-blind, controlled, phase III trial. Journal of the American Academy of Dermatology, 54(2), 242-250. https://doi.org/10.1016/j.jaad.2004.10.879